Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lidan Huatan Huoxue Formula is a Traditional Chinese Medicine (TCM) herbal prescription developed by the Shanghai Sixth People's Hospital, specifically within its Department of Endocrinology and Metabolism. Designed to treat metabolic syndrome and non-alcoholic fatty liver disease (NAFLD), the formula is based on TCM principles of clearing the gallbladder (Lidan), resolving phlegm (Huatan), and promoting blood circulation (Huoxue). It typically comprises a combination of medicinal herbs such as *Artemisia capillaris*, *Curcuma longa*, *Alisma plantago-aquatica*, and *Salvia miltiorrhiza*. Research indicates that the formula exerts its therapeutic effects by improving insulin sensitivity, regulating lipid metabolism, and reducing hepatic steatosis. Its mechanism of action involves the activation of metabolic regulators like AMPK and the modulation of the gut-liver axis and systemic inflammatory responses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lidan Huatan Huoxue Formula.